# Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

> **NCT02815709** · PHASE3 · COMPLETED · sponsor: **Trevena Inc.** · enrollment: 418 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Oliceridine
- **DRUG:** Placebo
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT02815709
- **Lead sponsor:** Trevena Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 418 (ACTUAL)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815709, "Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02815709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*